Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study
- 26 November 2018
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 72 (1) , 27-35
Abstract
Objective: The tender joint count (TJC) is included in composite disease activity scores (CDAS) (the Disease Activity Score in 28 joints, the Clinical Disease Activity Index, and the Simplified Disease Activity Index). The impact of having predominantly tender joints was explored by use of the Tender‐Swollen Joint Count Difference (TSJD), and ultrasound (US) provided a measure of joint inflammation. The current study aimed to explore the cross‐sectional and longitudinal associations between the TSJD and a spectrum of outcome measures, including US scores in patients with established rheumatoid arthritis (RA) during follow‐up and while receiving treatment with biologic disease‐modifying antirheumatic drugs (bDMARDs).Methods: This was an observational study of 209 patients with established RA consecutively included upon initiation of bDMARD treatment and followed‐up with clinical, laboratory, and comprehensive US examinations at 0, 1, 2, 3, 6, and 12 months. Patients were categorized into 2 groups: those with predominantly tender joints (TSJD >0) and those with predominantly swollen joints (TSJD ≤0). Statistical analyses included Pearson's correlation coefficient, an independent samples t‐test, and regression analyses.Results: The TJC had high correlations only with patient‐reported outcomes (PROMs) (P < 0.001). Levels from CDAS and PROMs were significantly higher (P < 0.001) at all visits in patients with TSJD >0 compared to those with TSJD P < 0.001–0.03). The baseline TSJD positively predicted levels of all CDAS at 6 months (P < 0.001–0.019) but was a negative predictor of US sum scores (gray‐scale and power Doppler) at 6 and 12 months (P < 0.001).Conclusion: Patients with predominantly tender joints had higher CDAS but lower levels of inflammation as defined by US. These findings indicate that inclusion of the TJC in the CDAS may contribute to misleading information about inflammatory activity.Keywords
Funding Information
- Pfizer, Norway
- AbbVie Norway
- Roche, Norway
This publication has 36 references indexed in Scilit:
- Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish CohortArthritis Care & Research, 2013
- Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiativeAnnals of the Rheumatic Diseases, 2011
- Fibromyalgic rheumatoid arthritis and disease assessmentRheumatology, 2010
- Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritisArthritis Care & Research, 2009
- Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread painBest Practice & Research Clinical Rheumatology, 2007
- Validating the Use of Two-Item Measures of Pain Beliefs and Coping Strategies for a Veteran PopulationThe Journal of Pain, 2006
- Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonographyAnnals of the Rheumatic Diseases, 2005
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ.Annals of the Rheumatic Diseases, 1992
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988